Dr. Sherry Boodram is the CEO and Co-Founder of CannDelta Inc., where she is responsible for providing guidance and developing strategies to ensure regulatory compliance within Canada’s existing cannabis and psychedelics frameworks as well as in international jurisdictions.
She is a leader in the cannabis and psychedelics industry, having spent several years in the Canadian federal government, most notably at Health Canada’s Medical Cannabis and Controlled Substances Programs as a Senior Regulatory Compliance and Enforcement Officer. Dr. Boodram has extensive knowledge and experience in regulatory and licensing submissions, international policy and regulation development, mergers and acquisitions, due diligence inspections and audits, internal quality management systems and processes, facility design and operational optimization, and education.
She serves as an Independent Board Advisor for Nextleaf Solutions Ltd. (CSE:OILS, OTCQB:OILFF), a Canadian cannabis extraction technology company, and also serves as an elected Board Member for the Canadian Association of Professionals in Regulatory Affairs (CAPRA).
Dr. Boodram holds a Ph.D. in Chemistry from York University, a Hon. B.Sc. in Biological Chemistry from the University of Toronto, a Certificate in Cannabis Law and Regulation from Osgoode Hall Law School of York University, and a Graduate Certificate with Honours in Pharmaceutical Regulatory Affairs and Quality Operations from Seneca College.